Cell Metab 36(10): 21732189
How Tirzepatide Works Tirzepatide is a GLP-1 receptor agonist that mimics natural gut hormones to reduce appetite, slow gastric emptying, and improve blood sugar regulation
In vitro studies revealed a dramatic increase in the number of cells expressing the intercellular adhesion molecule CD34 and an increase in the number of CD31 + cells with active esterase under the direct action of GLP-1, suggesting that endothelial progenitor cells expressing CD31 and CD34 endothelial progenitor cell markers may be targets of GLP-1 and participate in the regeneration process of damaged endothelium in emphysematous mice with heterotrophic insulin, 47 and thus in airway remodeling
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) currently in clinical trials for obesity and type 2 diabetes
Clearly, hydrophilic components, such as hydroxypyrrolidine, are not tolerated by the lipophilic S 1 domain